ISRCTN36315634已完成不适用
Mannitol to prevent an exacerbation of Complex Regional Pain Syndrome (CRPS) after hand surgery
niversity Medical Centre Utrecht (UMCU) (Netherlands)0 个研究点目标入组 50 人开始时间: 2006年1月27日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Age at least 18 years
- •2. History of CRPS, indicated by the presence of the following characteristics during the past 3 years (adapted CRPS I criteria according to Bruehl):
- •2.1. Continuing pain, disproportionate to any inciting event
- •2.2. At least 1 symptom in one of the following 4 categories:
- •2.2.1. Sensory: hyperalgesia
- •2.2.2. Vasomotor: temperature asymmetry or skin color changes or skin color asymmetry
- •2.2.3. Sudomotor/edema: edema or sweating changes or sweating asymmetry
- •2.2.4. Motor/trophic: diminished range of motion or motor dysfunction or trophic changes
- •3. The presence of CRPS signs is not mandatory
- •4. Surgery on the affected upper extremity (a.o. carpal-tunnel syndrome, joint surgery on wrist and fingers)
排除标准
- •1. Allergy to mannitol
- •2. Allergy to hydrochlorothiazide
- •3. Clinically relevant renal impairment (creatinine =150% normal)
- •4. History of cardiac failure (orthopnea, edema, exertional dyspnea, admissions for cardiac failure)
- •5. CRPS in both upper extremities
- •6. Other pain syndromes affecting functional testing or pain scores
- •7. Infection
- •8. Pregnancy
- •9. No informed consent
研究者
相似试验
已完成
不适用
Mannitol to prevent an exacerbation of Complex Regional Pain Syndrome (CRPS) after hand surgery.Complex Regional Pain SyndromeNL-OMON25885none50
已完成
3 期
Mannitol for acute kidney injury during liver transplantatioKidney DiseasePACTR202203622900599Mansoura University84
进行中(未招募)
不适用
ong Term Administration of Inahled Mannitol in Cystic Fibrosis - A Safety and Efficacy StudyCystic FibrosisEUCTR2008-002740-42-DEPharmaxis Pharmaceuticals Limited300
进行中(未招募)
1 期
ong Term Administration of Inahled Mannitol in Cystic Fibrosis - A Safety and Efficacy StudyMedDRA version: 9.1Level: LLTClassification code 10011762Term: Cystic fibrosisCystic FibrosisEUCTR2008-002740-42-FRPharmaxis Pharmaceuticals Limited318
进行中(未招募)
不适用
ong Term Administration of Inahled Mannitol in Cystic Fibrosis - A Safety and Efficacy StudyMedDRA version: 9.1Level: LLTClassification code 10011762Term: Cystic fibrosisCystic FibrosisEUCTR2008-002740-42-BEPharmaxis Pharmaceuticals Limited300
